{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T12:13:24Z","timestamp":1770984804403,"version":"3.50.1"},"reference-count":31,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background: Systemic lupus erythematosus (SLE) is a complex autoimmune disease that leads to systemic inflammation and damage across various organs, including the respiratory system. The prevalence of pleuropulmonary manifestations in SLE patients, particularly in Saudi Arabia, remains underexplored. Objective: This study aims to determine the frequency of pleuropulmonary involvement in SLE patients at King Fahd Hospital of the University (KFUH), Khobar, Saudi Arabia, and identify factors associated with the presence of such findings. Method: A retrospective analysis was conducted on adult SLE patients at KFUH, using hospital medical records for data collection on demographic characteristics, clinical features, and immunological markers. Pleuropulmonary involvement was defined based on high-resolution computed tomography (HRCT) findings. Statistical analyses evaluated associations between pleuropulmonary findings and clinical or immunological parameters. Results: Out of 207 SLE patients (mean age 39.9 years, 92.8% female), 17.4% showed pleuropulmonary involvement on HRCT, with pleurisy being the most prevalent manifestation, followed by pulmonary nodules. Significant associations were found between pleuropulmonary involvement and positive rheumatoid factor (p = 0.002), cardiac involvement (p = 0.002), and higher SLICC\/ACR damage index scores (p = 0.001). Patients with positive rheumatoid factor and elevated SLICC\/ACR damage index had increased odds of developing pleuropulmonary complications (3.73- and 7.28-fold, respectively). Conclusions: Pleuropulmonary involvement in SLE patients is associated with clinical and immunological markers, including rheumatoid factor, cardiac involvement, and higher SLICC\/ACR damage index scores. Recognizing these associations may improve the early detection and targeted management of high-risk patients.<\/jats:p>","DOI":"10.3390\/medicina61020181","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T03:40:17Z","timestamp":1737517217000},"page":"181","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Pleuropulmonary Involvement in Patients with Systemic Lupus Erythematosus as Detected by High-Resolution CT Scans: Clinical and Immunological Association"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9342-7887","authenticated-orcid":false,"given":"Manal A.","family":"Hasan","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, King Fahad Hospital of the University, Imam Abdulrahman Bin Faisal University, Dammam 34221, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maram A.","family":"Alismail","sequence":"additional","affiliation":[{"name":"College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam 34221, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9166-4337","authenticated-orcid":false,"given":"Danah R.","family":"Bokhari","sequence":"additional","affiliation":[{"name":"College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam 34221, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rehab F.","family":"Alghamdi","sequence":"additional","affiliation":[{"name":"College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam 34221, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zainab E.","family":"Alhalal","sequence":"additional","affiliation":[{"name":"College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam 34221, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3994-8216","authenticated-orcid":false,"given":"Safi G.","family":"Alqatari","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, King Fahad Hospital of the University, Imam Abdulrahman Bin Faisal University, Dammam 34221, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8483-6080","authenticated-orcid":false,"given":"Mohammed D.","family":"Al Shubbar","sequence":"additional","affiliation":[{"name":"College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam 34221, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-0039-1685537","article-title":"Pulmonary Complications of Systemic Lupus Erythematosus","volume":"40","author":"Hannah","year":"2019","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Amarnani, R., Yeoh, S.-A., Denneny, E.K., and Wincup, C. (2021). Lupus and the Lungs: The Assessment and Management of Pulmonary Manifestations of Systemic Lupus Erythematosus. Front. Med., 7.","DOI":"10.3389\/fmed.2020.610257"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/resp.12473","article-title":"Pulmonary manifestations in systemic lupus erythematosus: Association with disease activity","volume":"20","author":"Alamoudi","year":"2015","journal-title":"Respirology"},{"key":"ref_4","first-page":"1","article-title":"Primary respiratory disease in patients with systemic lupus erythematosus: Data from the Spanish rheumatology society lupus registry (RELESSER) cohort","volume":"20","author":"Borrell","year":"2018","journal-title":"Arthritis Res. Ther."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1177\/0961203317699284","article-title":"Pleuropulmonary involvement in patients with systemic lupus erythematosus from a Latin American inception cohort (GLADEL)","volume":"26","author":"Salinas","year":"2017","journal-title":"Lupus"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s43168-024-00266-1","article-title":"Subclinical pleuro-pulmonary disease in patients with SLE: Functional and radiological methods","volume":"18","author":"Hamed","year":"2024","journal-title":"Egypt. J. Bronchol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2147\/IJGM.S449068","article-title":"Pulmonary Manifestations of Systemic Lupus Erythematosus Among Adults in Aseer Region, Saudi Arabia","volume":"17","author":"Alhammadi","year":"2024","journal-title":"Int. J. Gen. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.12669\/pjms.311.6544","article-title":"Pulmonary manifestations of systemic lupus erythematosus patients with and without antiphospholipid syndrome","volume":"31","author":"Hamdani","year":"2014","journal-title":"Pak. J. Med. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4137\/CMAMD.S7667","article-title":"Asymptomatic Pulmonary Hypertension in Systemic Lupus Erythematosus","volume":"4","author":"Kamel","year":"2011","journal-title":"Clin. Med. Insights Arthritis Musculoskelet. Disord."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus ery-thematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"ref_13","first-page":"373","article-title":"The Systemic Lupus International Collaborating Clinics\/American College of Rheumatology (SLICC\/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison","volume":"27","author":"Gladman","year":"2000","journal-title":"J. Rheumatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e000078","DOI":"10.1136\/lupus-2014-000078","article-title":"Haematological manifestations of lupus","volume":"2","author":"Fayyaz","year":"2015","journal-title":"Lupus Sci. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1191\/0961203305lu2200oa","article-title":"Cardiac involvement in systemic lupus erythematosus","volume":"14","author":"Doria","year":"2005","journal-title":"Lupus"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.berh.2009.01.002","article-title":"Respiratory manifestations of systemic lupus erythematosus: Old and new concepts","volume":"23","author":"Medeiros","year":"2009","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"ref_17","first-page":"e13","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee, ElSayed, N.A., Aleppo, G., Bannuru, R.R., Bruemmer, D., Collins, B.S., Ekhlaspour, L., Gaglia, J.L., Hilliard, M.E., and Johnson, E.L. (2024). Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2024. Diabetes Care, 47, S20\u2013S42.","DOI":"10.2337\/dc24-S002"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Hyassat, D., Al-Saeksaek, S., Naji, D., Mahasneh, A., Khader, Y., Abujbara, M., El-Khateeb, M., and Ajlouni, K. (2022). Dyslipidemia among patients with type 2 diabetes in Jordan: Prevalence, pattern, and associated factors. Front. Public Health, 10.","DOI":"10.3389\/fpubh.2022.1002466"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/0961203307079042","article-title":"Systemic lupus erythematosus in a multiethnic US Cohort LUMINA XLVIII: Factors predictive of pulmonary damage","volume":"16","author":"Bertoli","year":"2007","journal-title":"Lupus"},{"key":"ref_21","first-page":"e41215","article-title":"Clinical Manifestations of Systemic Lupus Erythematosus in a Tertiary Center in Saudi Arabia","volume":"15","author":"AlOmair","year":"2023","journal-title":"Cureus"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s11845-017-1727-4","article-title":"Prevalence of pulmonary hypertension in systemic lupus erythematosus: A meta-analysis","volume":"187","author":"Lv","year":"2018","journal-title":"Ir. J. Med. Sci."},{"key":"ref_23","first-page":"76","article-title":"Interstitial lung disease in patients with systemic lupus erythematosus: A cohort study","volume":"52","author":"Senkal","year":"2021","journal-title":"Turk. J. Med. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2174\/1573397113666170704102444","article-title":"Cardiovascular and Pulmonary Manifestations of Systemic Lupus Erythematosus","volume":"13","author":"Tselios","year":"2017","journal-title":"Curr. Rheumatol. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejr.2017.02.002","article-title":"Clinical pattern in Egyptian systemic lupus erythematosus patients with pleuropulmonary involvement","volume":"39","author":"Gheith","year":"2017","journal-title":"Egypt. Rheumatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"86","DOI":"10.12669\/pjms.35.1.405","article-title":"Frequency and predictors of pulmonary hypertension in patients with Systemic Lupus Erythematosus","volume":"35","author":"Asif","year":"2019","journal-title":"Pak. J. Med. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1177\/0961203309106831","article-title":"The Euro-lupus project: Epidemiology of systemic lupus erythematosus in Europe","volume":"18","author":"Cervera","year":"2009","journal-title":"Lupus"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.autrev.2017.04.003","article-title":"Antiphospholipid antibodies can identify lupus patients at risk of pulmonary hypertension: A systematic review and meta-analysis","volume":"16","author":"Zuily","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejr.2013.06.001","article-title":"Pulmonary involvement in early systemic lupus erythematosus","volume":"35","author":"Habib","year":"2013","journal-title":"Egypt. Rheumatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"17103","DOI":"10.1038\/nrdp.2017.103","article-title":"Antiphospholipid syndrome","volume":"4","author":"Schreiber","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ejcdt.2013.12.019","article-title":"Detection of pulmonary involvement in lupus patients with and without clinical pulmonary symptoms","volume":"63","author":"Mohammad","year":"2014","journal-title":"Egypt. J. Chest Dis. Tuberc."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/2\/181\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:33:18Z","timestamp":1759919598000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/2\/181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,22]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["medicina61020181"],"URL":"https:\/\/doi.org\/10.3390\/medicina61020181","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,22]]}}}